Abstract
Twenty-five dogs were exposed to gradual coronary occlusion by placing Ameroid constrictors around the origins of the left circumflex and anterior descending coronary arteries. Previous experiments have demonstrated that these constrictors absorb water and, over a period of three weeks, narrow the cross-sectional area of the two arteries to 50% or less, and consequently cause the death of 80% of the experimental animals. Twelve of the 25 animals were fed 50 mg. of Persantin three times a day by mouth commencing one day before the operative procedure. Determinations of the concentration of the drug in the blood revealed a level consistent with that obtained in humans after the administration of therapeutic doses. Eleven of the 13 control animals died in the three-month experimental period while only six of the 12 treated animals expired. Injections of Schlesinger mass in all animals dying or killed following the experimental period demonstrated that Persantin significantly accelerated the development of intercoronary anastomoses in the treated group, and in the surviving animals produced a rich anastomotic network much in excess of that seen in the surviving animals in the control series that were exposed to hypoxia alone. On the basis of these experimental findings, it is suggested that Persantin may favourably alter the prognosis of many patients with coronary artery disease.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ELLIOT E. C. The effect of persantin on coronary flow and cardiac dynamics. Can Med Assoc J. 1961 Aug 26;85:469–476. [PMC free article] [PubMed] [Google Scholar]
- ENOS W. F., Jr, BEYER J. C., HOLMES R. H. Pathogenesis of coronary disease in American soldiers killed in Korea. J Am Med Assoc. 1955 Jul 16;158(11):912–914. doi: 10.1001/jama.1955.02960110018005. [DOI] [PubMed] [Google Scholar]
- KIESE M., LANGE G., RESAG K. [5,4-d] pyrimidine on the circulation of experimental myocardial infarct and healthy myocardium]. Z Gesamte Exp Med. 1960;132:426–435. [PubMed] [Google Scholar]
- KINSELLA D., TROUP W., McGREGOR M. Studies with a new coronary vasodilator drug: persantin. Am Heart J. 1962 Feb;63:146–151. doi: 10.1016/0002-8703(62)90190-4. [DOI] [PubMed] [Google Scholar]
- WEST J. W., BELLET S., MANZOLI U. C., MUELLER O. F. Effects of Persantin (RA8), a new coronary vasodilator, on coronary blood flow and cardiac dynamics in the dog. Circ Res. 1962 Jan;10:35–44. doi: 10.1161/01.res.10.1.35. [DOI] [PubMed] [Google Scholar]